Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.47 |
| ▸ | SCD | O00767 | 1/20 | 0.46 |
| ▸ | DGAT1 | O75907 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3731426 | 0.99 | L3MBTL1 (0.48) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL3729733 | 0.90 | SCD (0.57) | MEN1KMT2ANPC1RAB9ARXFP1 | |
| SCHEMBL3728387 | 0.90 | DGAT1 (0.52) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| Hydrochloric Acid SCHEMBL3725765 | 0.90 | SCD (0.57) | MEN1KMT2ANPC1RAB9ARXFP1 | |
| Hydrochloric Acid SCHEMBL3729245 | 0.89 | DGAT1 (0.51) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL13347614 | 0.89 | MEN1 (0.49) | MEN1KMT2ANPC1RAB9ARXFP1 | |
| SCHEMBL3737875 | 0.88 | L3MBTL1 (0.59) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| Hydrochloric Acid SCHEMBL3726986 | 0.88 | MEN1 (0.48) | MEN1KMT2ANPC1RAB9ARXFP1 | |
| SCHEMBL3733167 | 0.88 | NPC1 (0.61) | MEN1KMT2ANPC1RAB9ARXFP1 | |
| Hydrochloric Acid SCHEMBL3734681 | 0.87 | L3MBTL1 (0.58) | L3MBTL1MEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | BOUILLOT ANNE MARIE JEANNE | 2010-05-13 | — | — | US | claimed |
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | BOUILLOT ANNE MARIE JEANNE | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | SCD, SCD5, FADS2 | L3MBTL1 3539/4885MEN1 4844/4885KMT2A 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.